SF 13 - Can we limit gadolinium use in neuroimaging?
ECR 2021
4Lectures
42Minutes
4Speakers
Lectures
1
SF 13 - Gadolinium: an environmental issue
12:46G. Stroomberg, Nieuwegein / NL
Learning Objectives 1. To learn about the potential toxic effect of environmental free gadolinium. 2. To appreciate that gadolinium is an emerging contaminant in water resources. 3. To understand the need of monitoring gadolinium distribution in tap waters.
2
SF 13 - Gadolinium deposition: an update
07:33D. Stojanov, Nis / RS
Learning Objectives 1. To learn about the mechanisms involved in gadolinium deposition in the brain. 2. To understand stability differences of the types of gadolinium chelates and their relationship to gadolinium deposition in the brain. 3. To learn about the potential long-term adverse health effects of gadolinum deposition in the brain.
3
SF 13 - I don't need gadolinium
10:59T. Yousry, London / UK
Learning Objectives 1. To understand the rationale for reducing repetitive injections of gadolinium-based contrast agents. 2. To identify clinical situations in which gadolinium-based contrast agents have no added value for diagnostic and monitoring purposes. 3. To learn about the potential of unenhanced MRI techniques with quantitative image analysis to obtain gadolinium-analog information.
4
SF 13 - I always need gadolinium
11:32N. Anzalone, Milan / IT
Learning Objectives 1. To appreciate the excellent safety profile and tolerance of gadolinium-based contrast agents. 2. To learn that there is no documented clinical risk related with gadolinium deposition in the brain. 3. To learn about the added clinical value of gadolinium MRI for diagnosis and monitoring purposes in different neurologic disorders.
Description
SF 13-2
10 min
Gadolinium: an environmental issue
Gerard J. Stroomberg, Nieuwegein / Netherlands
Learning Objectives
1. To learn about the potential toxic effect of environmental free gadolinium. 2. To appreciate that gadolinium is an emerging contaminant in water resources. 3. To understand the need of monitoring gadolinium distribution in tap waters.
SF 13-3
10 min
Gadolinium deposition: an update
Dragan A. Stojanov, Nis / Serbia
Learning Objectives
1. To learn about the mechanisms involved in gadolinium deposition in the brain. 2. To understand stability differences of the types of gadolinium chelates and their relationship to gadolinium deposition in the brain. 3. To learn about the potential long-term adverse health effects of gadolinum deposition in the brain.
SF 13-4
10 min
I don't need gadolinium
Tarek A. Yousry, London / United Kingdom
Learning Objectives
1. To understand the rationale for reducing repetitive injections of gadolinium-based contrast agents. 2. To identify clinical situations in which gadolinium-based contrast agents have no added value for diagnostic and monitoring purposes. 3. To learn about the potential of unenhanced MRI techniques with quantitative image analysis to obtain gadolinium-analog information.
SF 13-5
10 min
I always need gadolinium
Nicoletta Emanuela Anzalone, Milano / Italy
Learning Objectives
1. To appreciate the excellent safety profile and tolerance of gadolinium-based contrast agents. 2. To learn that there is no documented clinical risk related with gadolinium deposition in the brain. 3. To learn about the added clinical value of gadolinium MRI for diagnosis and monitoring purposes in different neurologic disorders.
15 min
Live Q&A: Towards practice harmonisation
PEP Subscription Required
This course is only accessible for ESR Premium Education Package subscribers.